研究目的
To report a case of diode laser transscleral cyclophotocoagulation (DLTSC) for uveitis-glaucoma-hyphema syndrome (UGH).
研究成果
DLTSC offers a minimally invasive treatment option for UGH syndrome when the IOL is slightly tilted, with minimal damage and no risk of infections. However, it is not applicable for severely tilted IOLs.
研究不足
The study is limited by its focus on a single case, which may not be representative of all UGH syndrome cases. Additionally, the applicability of DLTSC is restricted to cases where the IOL is only slightly tilted.
1：Experimental Design and Method Selection:
The study reports a clinical case where DLTSC was used to treat UGH syndrome. The methodology involved a detailed patient examination, diagnosis, and the application of DLTSC as a treatment intervention.
2：Sample Selection and Data Sources:
The case involved a single patient who developed UGH syndrome after vitrectomy and IOL implantation. Data sources included clinical examinations, BCVA, IOP measurements, B-scan ultrasound, and UBM.
3：List of Experimental Equipment and Materials:
The OcuLight SLx 810 nm diode laser photocoagulator and the handheld fiberoptic G-probe were used for the DLTSC procedure.
4：Experimental Procedures and Operational Workflow:
The DLTSC was performed under local anesthesia with specific laser settings and application points.
5：Data Analysis Methods:
Clinical outcomes were assessed through follow-up examinations, including BCVA, IOP measurements, and UBM imaging.
独家科研数据包，助您复现前沿成果，加速创新突破
获取完整内容
